Loading clinical trials...
Loading clinical trials...
The overall objective of this study is to examine the effect of polyamine supplementation on cognitive performance and further characterization of individuals with subjective cognitive decline.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Charite University, Berlin, Germany
Collaborators
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
NCT07286448 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT07212504 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT06403345 · Mild Cognitive Impairment, Alzheimer Disease, and more
Charité University Medicine Berlin, CCM, Department of Neurology,
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions